- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 19.12. | Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements | 2 | GlobeNewswire (USA) | ||
| 19.12. | Mangoceuticals announces $100 million Solana-focused strategy | 2 | Investing.com | ||
| 19.12. | Mangoceuticals setzt auf Solana: Neue Treasury-Strategie über 100 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 19.12. | Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy | 7 | GlobeNewswire (USA) | ||
| 19.12. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.12. | Mangoceuticals prices $2.5M registered direct offering with warrants | 1 | Seeking Alpha | ||
| 18.12. | Mangoceuticals secures $2.5 million through registered direct offering | 4 | Investing.com | ||
| 18.12. | Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 10.12. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11. | Eli Lilly and Novo Nordisk disown Mangoceuticals' GLP-1RA partnership claim | 39 | Pharmaceutical Technology | ||
| 14.11. | Mangoceuticals plunges after denying Lilly, Novo partnerships | 22 | Seeking Alpha | ||
| 14.11. | Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | 2.173 | GlobeNewswire (Europe) | Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier... ► Artikel lesen | |
| 13.11. | Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals | 39 | FiercePharma | ||
| 13.11. | Mangoceuticals: Aktie stürzt nach Dementi von Novo Nordisk und Eli Lilly ab | 53 | Investing.com Deutsch | ||
| 13.11. | Lilly, Novo in pact with Mangoceuticals for direct sales of weight loss drugs | 50 | Seeking Alpha | ||
| 13.11. | Mangoceuticals launches direct GLP-1 medication access programs | 21 | Investing.com | ||
| 13.11. | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.09. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.09. | MANGOCEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,141 | +2,47 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| NUWELLIS, INC | 2,020 | -2,42 % | Nuwellis, Inc.: Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum | MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing... ► Artikel lesen | |
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| ENVUE MEDICAL | 2,640 | -4,35 % | ENvue Medical, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| HEARTFLOW | 29,830 | -2,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ATRICURE | 40,330 | -0,54 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.09.2025 | The following instruments on XETRA do have their first trading 18.09.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.09.2025
Aktien
1 US64119N6085 Netskope Inc.
2 IE00BFY8C754... ► Artikel lesen | |
| GENEDX | 134,29 | -1,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| RXSIGHT | 10,930 | -4,62 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen |
MANGOCEUTICALS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,057 (-7,44 %) liegt der Kurs bei 0,713 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.